{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:48:12Z","timestamp":1779122892387,"version":"3.51.4"},"reference-count":35,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,9,6]],"date-time":"2007-09-06T00:00:00Z","timestamp":1189036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2007,11]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> The haematologist medical directors of the Hemophilia Region III Treatment Centers in the mid\u2010Atlantic Region III of the United States identified individuals in their databases diagnosed with additional congenital coagulopathies co\u2010expressing with Von Willebrand\u2019s disease (VWD) and its variants. Sixteen individuals from 14 unrelated families, originating from five institutions, had been evaluated comprehensively. They represented approximately 1.5% of the calculated VWD population (<jats:italic>n<\/jats:italic>\u2003=\u2003986) registered in region III at the end of year 2002. Eleven of the 16 (68.75%) had type 1 VWD; two (12.5%) had type 2A; two (12.5%) had type 2 Normandy (2N) and one (6.25%) had coexisting type 2B and type 2N VWD. The accompanying coagulopathies consisted of severe or moderate factor VIII (FVIII) deficiency (haemophilia A) in six (37.5%); severe or moderate factor IX deficiency (haemophilia B) in three (18.75%); severe or moderate factor XI deficiency in two (12.5%); severe factor VII deficiency in two (12.5%); combined factor XI and XII deficiencies in one (6.25%); qualitative platelet abnormality in one (6.25%); and one had combined type 2B and type 2N VWD (6.25%). The reversal of overt bleeding often required multiple therapeutic modalities, mandated by the specific combination of coagulation disorders. This included administration of specific purified clotting factor concentrates, cryoprecipitate, fresh frozen plasma, 1,8 deamino\u2010<jats:sc>d<\/jats:sc>\u2010arginine vasopressin, antifibrinolytic agents, platelet transfusions, etc. In summary, combined inherited coagulopathies coexisting with VWD are uncommon and frequently are phenotypically divergent from VWD. Successful therapy required an individualized approach, employing multiple replacement strategies, based on the laboratory definition of the specific additional coagulation defect.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2007.01541.x","type":"journal-article","created":{"date-parts":[[2007,9,8]],"date-time":"2007-09-08T08:59:27Z","timestamp":1189241967000},"page":"685-696","source":"Crossref","is-referenced-by-count":21,"title":["Multiple congenital coagulopathies co\u2010expressed with Von Willebrand\u2019s disease: the experience of Hemophilia Region III Treatment Centers over 25\u2003years and review of the literature"],"prefix":"10.1111","volume":"13","author":[{"given":"E.","family":"ASATIANI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"KESSLER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"ON BEHALF OF THE DIRECTORS OF THE COMPREHENSIVE HEMOPHILIA TREATMENT CENTERS IN REGION III","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,9,6]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.00302.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V69.2.454.454"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-2712(18)30929-6"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113871"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113721"},{"key":"e_1_2_5_7_2","first-page":"94","article-title":"von Willebrand\u2019s disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment","volume":"88","author":"Castaman G","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2257.2001.00400.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1642471"},{"key":"e_1_2_5_10_2","first-page":"1110","article-title":"Combined hemophilia A and type 2 von Willebrand\u2019s disease: defect of both factor VIII level and factor VIII binding capacity of von Willebrand factor","volume":"86","author":"Casonato A","year":"2001","journal-title":"Haematologica"},{"key":"e_1_2_5_11_2","first-page":"57","article-title":"Combined haemophilia A and type I von Willebrand\u2019s disease: a family study including an evaluation of the effects of DDAVP infusion","volume":"25","author":"Casonato A","year":"1993","journal-title":"Haematologia (Budap)"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320240110"},{"key":"e_1_2_5_13_2","first-page":"782","article-title":"Association of von Willebrand\u2019s disease and factor IX deficiency in males and females of a family","volume":"28","author":"Linares Ruiz MS","year":"1983","journal-title":"Sangre (Barc)"},{"key":"e_1_2_5_14_2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-0038-1650544","article-title":"Combined hereditary disorders of haemophilia B Leyden (\u20106 G\u2013>A) and type 1 von Willebrand disease","volume":"76","author":"Pernod G","year":"1996","journal-title":"Thromb Haemost"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199107183250303"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V51.6.1223.1223"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/74.1.108"},{"key":"e_1_2_5_18_2","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1182\/blood.V16.2.1184.1184","article-title":"Combined deficiencies of PTA and AHG","volume":"16","author":"Perrys S","year":"1960","journal-title":"Blood"},{"key":"e_1_2_5_19_2","article-title":"Combined factor XI and factor VIII deficiency in one family","author":"Gordon S","year":"1975","journal-title":"Sixteenth Congress of International Society on Hematology"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830440211"},{"key":"e_1_2_5_21_2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-0038-1645682","article-title":"The effect of combined factor XI deficiency with von Willebrand factor abnormalities on haemorrhagic diathesis","volume":"63","author":"Tavori S","year":"1990","journal-title":"Thromb Haemost"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830010306"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199711000-00005"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01732874"},{"key":"e_1_2_5_25_2","first-page":"3967","article-title":"Mutations in the human factor XII gene","volume":"90","author":"Schloesser M","year":"1997","journal-title":"Blood"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1647467"},{"key":"e_1_2_5_27_2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-0037-1614053","article-title":"Prevalence of clotting factor deficiencies in a large population with von Willebrand disease","volume":"84","author":"Nitu\u2010Whalley IC","year":"2000","journal-title":"Thromb Haemost"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01716807"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1999.tb01023.x"},{"key":"e_1_2_5_30_2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood.V96.1.374","article-title":"Clinical manifestations, management, and molecular genetics in congenital factor VII deficiency: the International Registry on Congenital Factor VII Deficiency (IRF7)","volume":"96","author":"Mariani G","year":"2000","journal-title":"Blood"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199304010-00031"},{"key":"e_1_2_5_32_2","first-page":"119","article-title":"Congenital deficiency of factor VII in combination with Willebrand\u2019s syndrome","volume":"54","author":"Lychev VG","year":"1982","journal-title":"Ter Arkh"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-200011020-00006"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2000.00345.x"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.00319.x"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01562.x"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2007.01541.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2007.01541.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:39:18Z","timestamp":1697229558000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2007.01541.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["10.1111\/j.1365-2516.2007.01541.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2007.01541.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,6]]}}}